Investors

Date	Name	Title	Type	Shares Traded	Price Range
Nov 26, 2012	baker charles a	Director	Option Execute	15,000	9.17
Sep 5, 2012	baker charles a	Director	Option Execute	1,286	15.01
Sep 6, 2012	baker charles a	Director	Option Execute	13,714	15.01
Jul 1, 2011	baker charles a	Director	Option Execute	11,000	28.81
Jun 2, 2010	baker charles a	Director	Option Execute	5,000	25.43
Feb 20, 2009	baker charles a	Director	Option Execute	10,000	7.66
Feb 15, 2008	baker charles a	Director	Option Execute	10,000	7.91
Nov 5, 2007	brown michael s	Director	Option Execute	10,000	7.91
Sep 9, 2008	brown michael s	Director	Option Execute	5,000	7.66
Feb 23, 2009	brown michael s	Director	Option Execute	5,000	7.66
Oct 6, 2010	brown michael s	Director	Option Execute	5,000	18.80
May 18, 2010	brown michael s	Director	Option Execute	5,000	25.43
Dec 17, 2010	brown michael s	Director	Option Execute	5,000	18.80
Jul 1, 2011	brown michael s	Director	Option Execute	25,000	15.80 - 28.81
Mar 30, 2011	brown michael s	Director	Option Execute	5,000	15.01
Jan 18, 2011	brown michael s	Director	Option Execute	10,000	15.01 - 18.80
Mar 9, 2011	brown michael s	Director	Option Execute	5,000	15.01
Aug 6, 2012	brown michael s	Director	Option Execute	3,000	23.84
Oct 25, 2012	brown michael s	Director	Option Execute	2,000	23.84
Oct 26, 2012	brown michael s	Director	Option Execute	3,000	23.84
Showing 381-400 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.